For pharma · biotech · CRO
Stop hunting for patients. See who already fits.
We don't go looking for patients. Patients come to us, self-pre-screen against your protocol, and raise their hand. Your sites open with a consented, eligible funnel, before you commit a site visit.
- How a biotech reached a consented funnel in under 5 months, with no outreach.
- How patients filter out obvious mismatches before sites get involved.
- What an early fit signal does to enrolment confidence, before you spend on sites.
Built with Innodia, UZ Gent, CHU Brugmann, Dedalus and 20+ more across Europe.
Trusted across Europe's clinical research network
Backed by 20+ patient organisations, hospitals, and research bodies across Europe.
GDPR-native · EU AI Act compliant · pre-screening outside Ethics Committee scope by design
The problem
Recruitment is the bottleneck. Everywhere.
Recruitment is the biggest cause of trial delays. Sites are overloaded, eligible patients are hard to reach, and screen failures eat the funnel before randomisation. For a small team running a handful of trials, there's no spare bandwidth to absorb a miss.
Site overload
Coordinators screen out most leads before anyone qualifies.
Funnel mismatch
Plans assume an ideal patient who barely exists. Tighter criteria collapse the curve early.
No pre-site visibility
You're blind until the first screen. By then the budget to fix it is gone.
Patient engagement, by design
Patients reach us. They see what fits them.
Curewiki is patient-initiated. People come to us through their patient organisation, their hospital, or directly, and register their willingness to take part. When a study opens, we surface it to the patients who fit.
Patients register willingness
Direct, consented, patient-initiated.
Your study opens
We translate criteria into patient-friendly self-pre-screening.
Patients identify their fit
Obvious mismatches filter themselves out.
Sites do final screening
Sites get a warmer funnel and a clear fit signal. We stay out of the clinical decision.
What we run on the platform
Four ways patients reach research.
Curewiki supports the patient engagement work around a clinical trial, with one patient-facing network across all of it.
Patient panel composition
Consented panels across rare and chronic indications, from patients who already raised their hand.
Cohort surveys
Structured surveys against opted-in cohorts. Zero-party data, ready for analysis.
Pre-screening for trials
Patients self-pre-screen against simplified criteria. Mismatches filter out before a site sees them.
Real-world data insights
Longitudinal signal from declared health journeys over time. For feasibility, and beyond.
Real-world data
At the source. With consent.
Patient data is declared by the patient, with explicit consent. No data brokers, no intermediaries. The same record reaches sponsor, site, and patient.
What patients share
- Their own declared health profile
- Self-pre-screening answers
- Willingness to re-engage over time
What you get
- An eligibility signal
- Cohort feasibility
- Engagement metrics
Zero-party. Patients declare their own information. No scraping, no purchased lists.
Full consent. Every record carries explicit, revocable consent, audit-logged and aligned to GDPR Article 9.
Patient control. Patients see what they share and with whom, and can revoke at any moment.
Easier review. Sponsor and patient see the same record, which simplifies legal and procurement checks.
Ecosystem
Expert-led. Tech-driven. Patient-first.
We work with patient organisations, hospitals, and research infrastructure that sit inside the platform. The network does the heavy lifting.
Patient organisations
Innodia
European Type 1 Diabetes consortium.
Patient Expert Center
Belgian patient-expert umbrella.
TEDDY
European paediatric research network.
ELPA
European Liver Patients Association.
BAOB
Belgian brain and oncology advocacy.
De Roze Doos
Belgian channel to young parents.
Amybel
Belgian amyloidosis organisation.
Alzheimer Liga
Flemish Alzheimer's association.
Behind Endo
Endometriosis awareness and research.
POP
Spanish chronic-illness umbrella.
ADER
Spanish rare disease association.
Pancreatic Cancer Europe
Pancreatic cancer research platform.
Hospitals
UZ Gent
T1D pre-screening at scale.
InoKura
Phase I and II centre, Liège.
CHU Brugmann
Brussels public university hospital.
Tech & research infrastructure
Dedalus
Integration partner, xShare Gold.
READi
Horizon Europe IHI project.
Sciensano
Belgian public health institute.
VITO
Research org, xShare Bronze.
Compliance
Compliance-native by design.
Every pharma buyer asks two questions first: GDPR and security. Both packs are ready on request. For Ethics Committee questions, our regulatory one-pager covers our position.
GDPR, operational
Our technical team is based in Belgium and we operate under GDPR.
OperationalEU AI Act, compliant
Risk classification mapped, model documentation maintained, human oversight built in.
CompliantEthics Committee position
Pre-screening sits outside EC scope: patient-initiated, neutral, never study-specific.
DocumentedISO 27001
Implementation underway. Certification expected this fiscal year.
In progressNext step
Built for your next trial.
See the mechanism, the timeline, and what an early fit signal does to a funnel. One page, two minutes, ready to circulate internally.
Prefer to talk it through first? Book a 30-minute intro →